Rebecca Pulk
Yale New Haven Health System(US)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Pharmacogenetics and Drug Metabolism, Pharmaceutical studies and practices, Pharmaceutical Practices and Patient Outcomes, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators(2005)97 cited
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes(2018)85 cited
- → A Class of 2,4-Bisanilinopyrimidine Aurora A Inhibitors with Unusually High Selectivity against Aurora B(2009)81 cited
- → Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2(2013)62 cited
- → Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2(2012)61 cited
- → Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection(2021)49 cited
- → Potent and Selective Aminopyrimidine-Based B-Raf Inhibitors with Favorable Physicochemical and Pharmacokinetic Properties(2012)47 cited
- → 2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitors(2013)44 cited
- → Multigene Predictors of Tacrolimus Exposure in Kidney Transplant Recipients(2015)36 cited
- → Developing Pharmacogenomic Reports: Insights from Patients and Clinicians(2018)28 cited